Education
About Us
Working with TipRanks
Follow Us
Torben Lund-Hansen Insider Profile
4 Followers
Torben Lund-Hansen, SVP & CTO at Y-Mabs Therapeutics, holds 81.26K shares in Y-Mabs Therapeutics (Ticker: YMAB).
Torben Lund-Hansen Y-Mabs Therapeutics (YMAB)SVP & CTO
Y-Mabs Therapeutics (YMAB)
SVP & CTO
Not Ranked
Torben Lund-Hansen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Torben Lund-Hansen does not currently own shares as a corporate insider.
A breakdown of Torben Lund-Hansen's holdings
Insider Roles
Torben Lund-Hansen does not currently hold a role as a corporate insider.
Roles that Torben Lund-Hansen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Torben Lund-Hansen
Torben Lund-Hansen's Trading History
List of latest transactions for each holding click on a transaction to see Torben Lund-Hansen's performance on stock
You May Also Like
Torben Lund-Hansen insider profile FAQ
What is the percentage of profitable transactions made by Torben Lund-Hansen?
The percentage of profitable transactions made by Torben Lund-Hansen is ―.
What is the average return per transaction made by Torben Lund-Hansen?
The average return per transaction made by Torben Lund-Hansen is ―.
What stocks does Torben Lund-Hansen hold?
Torben Lund-Hansen holds: YMAB stocks.
What was Torben Lund-Hansen’s latest transaction?
Torben Lund-Hansen latest transaction was an Uninformative Buy of $219.00K.
What was Torben Lund-Hansen's most profitable transaction?
Torben Lund-Hansen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Torben Lund-Hansen's role in Y-Mabs Therapeutics?
Torben Lund-Hansen's role in Y-Mabs Therapeutics is SVP & CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.